Rationale for (-) deprenyl (selegiline) therapy in parkinson's disease and alzheimer's disease
Document title: Rationale for (-) deprenyl (selegiline) therapy in parkinson's disease and alzheimer's disease
Journal: Revista brasileira de neurologia
Database: PERIÓDICA
System number: 000024003
ISSN: 0101-8469
Authors: 1
Institutions: 1Semmelweis University of Medicine, Dept Pharmacology, Budapest. Hungría
Year:
Season: May-Jun
Volumen: 31
Number: 3
Pages: 131-138
Country: Brasil
Language: Inglés
Document type: Revisión bibliográfica
Approach: Descriptivo
Disciplines: Medicina
Keyword: Farmacología,
Medicina experimental,
Neurología,
Terapéutica y rehabilitación,
Selegilina,
Enfermedad de Alzheimer,
Enfermedad de Parkinson
Keyword: Medicine,
Experimental medicine,
Neurology,
Pharmacology,
Therapeutics and rehabilitation,
Selegiline,
Alzheimer disease,
Parkinson disease
Document request
Note: The document is shipping cost.









Original documents can be consulted at the Departamento de Información y Servicios Documentales, located in the Annex to the General Directorate of Libraries (DGB), circuito de la Investigación Científica across from the Auditorium Nabor Carrillo, located between the Institutes of Physics and Astronomy. Ciudad Universitaria UNAM. Show map
For more information: Departamento de Información y Servicios Documentales, Tels. (5255) 5622-3960, 5622-3964. E-mail: sinfo@dgb.unam.mx . Monday to Friday from (8 to 16 hrs).